City Pedia Web Search

Search results

1. Results From The WOW.Com Content Network

2. Eszopiclone - Wikipedia

   en.wikipedia.org/wiki/Eszopiclone

   Eszopiclone is classified as a nonbenzodiazepine or Z-drug and a sedative and hypnotic of the cyclopyrrolone group. [ 7] It is the S- stereoisomer of zopiclone. [ 5][ 8] It works by interacting with the GABA receptors. [ 7] Approved for medical use in the United States in 2004, [ 3] eszopiclone is available as a generic medication. [ 5]

3. Zolpidem - Wikipedia

   en.wikipedia.org/wiki/Zolpidem

   Zolpidem, sold under the brand name Ambien among others, is a medication primarily used for the short-term treatment of sleeping problems. [10] [12] Guidelines recommend that it be used only after cognitive behavioral therapy for insomnia and after behavioral changes, such as sleep hygiene, have been tried.

4. Can Sleeping Pills Raise the Risk of Dementia? New Study ...

   www.aol.com/sleeping-pills-raise-risk-dementia...

   About 4% of adults over the age of 20 use prescription sleeping pills in the U.S., but a new study is raising eyebrows after linking these common sleep aids to dementia. The study, which was ...

5. Memantine - Wikipedia

   en.wikipedia.org/wiki/Memantine

   Memantine. Memantine, sold under the brand name Axura among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. [ 7][ 8] It is taken by mouth. [ 7] Common side effects include headache, constipation, sleepiness, and dizziness. [ 7][ 8] Severe side effects may include blood clots, psychosis, and heart ...

6. What Stage of Dementia Is Sundowning? (and How to Manage It)

   www.aol.com/stage-dementia-sundowning-manage...

   Dementia is a progressive condition that gradually worsens over time. Clinically, healthcare providers break dementia into seven stages, as follows: Stage 1: The appearance of being cognitively ...

7. Semaglutide linked to lower cognitive decline risk and ...

   www.aol.com/semaglutide-linked-lower-cognitive...

   Additionally, these medications were linked to a reduced the risk of dementia and also less craving for nicotine. The study is published in eClinicalMedicine , part of The Lancet Discovery Science .